Clinitech Laboratory SME IPO Details, Financials, Valuation & Peers

Clinitech Laboratory Limited is a provider of diagnostic and healthcare tests and services, operating a chain of eight diagnostic centers located in and around Thane and Navi Mumbai. With over 30 years of experience in the diagnostic business, Clinitech conducts more than 3 Lakh tests annually in its NABL-accredited laboratories, which are equipped with modern technology and high-end equipment. The company offers a comprehensive range of tests, including biochemistry, immunology, hematology, molecular biology, serology, microbiology, and histopathology.

Key Points:

• Range of Tests:
  • Biochemistry Tests
  • Immunology Tests
  • Hematology Tests
  • Molecular Biology Tests
  • Serology Tests
  • Microbiology Tests
  • Histopathology Tests
• Patient and Test Volume: In FY 2024, the company served 95,946 patients and conducted 344,467 tests.
• Customer Segments:
  • B2B (Hospitals and Contract Research Organizations): ₹ 1.30 crore (20.33%) in FY 2024.
  • B2C (Individual walk-in customers): ₹ 5.10 crore (79.67%) in FY 2024.

Competitive Strengths:

• NABL Accreditation:
  • Certification ensures high quality of services, fostering customer confidence.
• Chain of Diagnostic Centers:
  • Eight centers across Thane, Raigad, and Navi Mumbai, providing accessible services.
  • Established trust with customers over 30+ years.
• Experienced Promoters and Management:
  • Promoters Jagdish Umakant Nayak and Jyoti Jagdish Nayak have over 30 years of experience.
  • Experienced senior management team with expertise in technical, customer relationship, operational, marketing, and business development.
• Strong Customer Relationships:
  • Long-standing relationships with customers, leading to repeat business and cross-selling opportunities.
  • Aim to be the "first choice service provider" for diagnostic services.